Posterior insular cortex hyperactivation drives vestibular migraine and comorbid anxiety
Abstract
BACKGROUND: Vestibular migraine, a debilitating disorder characterized by recurrent episodes of headache and vertigo, is frequently comorbid with persistent anxiety and depression. The neural mechanisms that integrate these disparate sensory and affective symptoms remain elusive. FINDINGS: Here, we combined clinical characterization with a translational mouse model to identify the posterior insular cortex (pIC) as a critical hub driving the pathophysiology of vestibular migraine. In patients, anxiety and depression scores remained elevated interictally, suggesting a trait-like affective disturbance. Using a validated mouse model combining nitroglycerin (NTG) administration and rotarod vestibular stimulation, which recapitulates vestibular migraine-like phenotypes (hyperalgesia, balance deficits, and anxiety-like behaviors), we observed hyperactivity within the pIC. This region responded to both nociceptive and vestibular challenges. Chemogenetic inhibition of the pIC reversed hyperalgesia and vestibular-motor deficits. Notably, while acute inhibition did not affect anxiety-like behaviors, chronic inhibition produced a full rescue, including the affective component, paralleling the clinical persistence of mood symptoms. Conversely, chronic chemogenetic activation of the pIC was sufficient to promote all core phenotypes under a subthreshold NTG regimen combined with rotarod vestibular stimulus. Furthermore, systemic administration of the NMDA receptor antagonist memantine…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.